These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2488379)

  • 1. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Passlick J; Wonner R; Keller E; Essers L; Grabensee B
    Perit Dial Int; 1989; 9(4):267-72. PubMed ID: 2488379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients.
    Kampf D; Borner K; Hain H; Conrad W
    Perit Dial Int; 1991; 11(4):317-21. PubMed ID: 1751596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis.
    Cheng IK; Chau PY; Kumana CR; Chan CY; Kou M; Siu LK
    Perit Dial Int; 1993; 13 Suppl 2():S383-5. PubMed ID: 8399617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nikolaidis P; Walker SE; Dombros N; Tourkantonis A; Paton TW; Oreopoulos DG
    Perit Dial Int; 1991; 11(1):59-63. PubMed ID: 2049424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
    Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin.
    Chan MK; Chau PY; Chan WW
    J Antimicrob Chemother; 1988 Sep; 22(3):371-5. PubMed ID: 3182430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
    Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Chan MK; Chau PY; Chan WW
    Clin Nephrol; 1987 Dec; 28(6):277-80. PubMed ID: 3481692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Nikolaidis P; Dombros N; Alexiou P; Balaskas E; Tourkantonis A
    Perit Dial Int; 1989; 9(1):57-9. PubMed ID: 2488183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral treatment of peritonitis in CAPD patients with ofloxacin.
    Chan MK; Chau PY; Chan WW
    Nephrol Dial Transplant; 1988; 3(2):194-7. PubMed ID: 3140086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ofloxacin pharmacokinetics in chronic renal failure and dialysis.
    Lameire N; Rosenkranz B; Malerczyk V; Lehr KH; Veys N; Ringoir S
    Clin Pharmacokinet; 1991 Nov; 21(5):357-71. PubMed ID: 1773550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?
    Gucek A; Bren AF; Lindic J; Hergouth V; Mlinsek D
    Adv Perit Dial; 1994; 10():144-6. PubMed ID: 7999813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis.
    McMullin CM; Brown NM; Brown IM; Tomson CR; White LO; Reeves DS; MacGown AP
    J Antimicrob Chemother; 1997 Jun; 39(6):829-31. PubMed ID: 9222057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis.
    Kampf D; Borner K; Pustelnik A
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():61-8. PubMed ID: 2286592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
    Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
    Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis.
    Fleming LW; Moreland TA; Scott AC; Stewart WK; White LO
    J Antimicrob Chemother; 1987 Apr; 19(4):493-503. PubMed ID: 3583969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin: an assessment of its pharmacokinetics and therapeutic potential in CAPD.
    Kent JR; Almond MK; Dhillon S
    Perit Dial Int; 2001; 21(4):372-7. PubMed ID: 11587400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
    Neal D; Bailie GR
    Clin Pharmacokinet; 1990 Jun; 18(6):485-90. PubMed ID: 2354591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.